{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:31:49Z","timestamp":1786710709205,"version":"build-2736575974"},"reference-count":132,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.adro.2026.102087","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:59:43Z","timestamp":1779206383000},"page":"102087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of In Vitro and Clinical Alpha\/Beta Estimates With Potential Impact of Tumor Heterogeneity"],"prefix":"10.1016","volume":"11","author":[{"given":"Cameron","family":"Thayer-Freeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William St","family":"Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2026.102087_bib0001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1088\/1361-6560\/aaf26a","article-title":"The linear quadratic model: Usage, interpretation and challenges","volume":"64","author":"McMahon","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.adro.2026.102087_bib0002","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1088\/0031-9155\/21\/3\/001","article-title":"Radiation and the single cell: The physicist\u2019s contribution to radiobiology","volume":"21","author":"Hall","year":"1976","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.adro.2026.102087_bib0003","series-title":"Basic Clin Radiobiol","first-page":"89","article-title":"The radiosensitivity of tumor cell in vitro versus in vivo","author":"Chapman","year":"2009"},{"key":"10.1016\/j.adro.2026.102087_bib0004","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/1831060a0","article-title":"A survival curve for mammalian cells irradiated in vivo","volume":"183","author":"Hewitt","year":"1959","journal-title":"Nature"},{"key":"10.1016\/j.adro.2026.102087_bib0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0167-8140(89)90070-4","article-title":"A comparison of the in vivo and in vitro radiation response of three human cervix carcinomas","volume":"16","author":"Kelland","year":"1989","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0006","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0360-3016(90)90098-5","article-title":"Comparison between in vitro radiosensitivity and in vivo radioresponse in murine tumor cell lines II: In vivo radioresponse following fractionated treatment and in vitro\/in vivo correlations","volume":"18","author":"Bristow","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0007","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br J Radiol"},{"key":"10.1016\/j.adro.2026.102087_bib0008","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1088\/0031-9155\/49\/19\/003","article-title":"Comparison of in vitro and in vivo \u03b1\/\u03b2 ratios for prostate cancer","volume":"49","author":"David","year":"2004","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.adro.2026.102087_bib0009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","article-title":"Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial","volume":"75","author":"Yarnold","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0010","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0360-3016(86)90071-4","article-title":"Distribution of radiation sensitivities for human tumor cells of specific histological types: Comparison of in vitro to in vivo data","volume":"12","author":"Malaise","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0011","first-page":"747","article-title":"Prospective comparison of in vitro normal cell radiosensitivity and clinical reaction severity in patients after radiotherapy","volume":"26","author":"Geara","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.adro.2025.101725","article-title":"In vitro \u03b1\/\u03b2 ratio variations in cervical cancer, with consequent effects on equivalent dose in 2 Gy fraction in high dose rate brachytherapy","author":"Thayer-Freeman","year":"2025","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0013","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4161\/cc.8.3.7608","article-title":"Does the cell number 10\u2079 still really fit one gram of tumor tissue?","volume":"8","author":"Del Monte","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.adro.2026.102087_bib0014","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1200\/JCO.2005.06.153","article-title":"Randomized trial comparing two fractionation schedules for patients with localized prostate cancer","volume":"23","author":"Lukka","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijrobp.2005.12.007","article-title":"An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk","volume":"65","author":"Williams","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0016","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the mRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0017","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ijrobp.2007.01.008","article-title":"What dose of external-beam radiation is high enough for prostate cancer?","volume":"68","author":"Eade","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0018","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2007.10.004","article-title":"Ultra-high dose (86.4 Gy) ImRT for localized prostate cancer: Toxicity and biochemical outcomes","volume":"71","author":"Cahlon","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0019","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ijrobp.2007.11.066","article-title":"Long-term results of conformal radiotherapy for prostate cancer: Impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes","volume":"71","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.radonc.2009.09.001","article-title":"Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma","volume":"93","author":"Aizer","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0021","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00066-009-1970-3","article-title":"Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial","volume":"185","author":"Goldner","year":"2009","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.adro.2026.102087_bib0022","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ijrobp.2008.10.087","article-title":"Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: A nonrandomized contemporary comparison","volume":"74","author":"Leborgne","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0023","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ijrobp.2010.08.044","article-title":"Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies","volume":"79","author":"Jain","year":"2011","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0024","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1006\/gyno.1996.0162","article-title":"Increased radiosensitivity by a combination of 9-cis-retinoic acid and interferon-\u03b3 in breast cancer cells","volume":"61","author":"Windbichler","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/09553000110089991","article-title":"Ukrain\u00ae, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation","volume":"78","author":"Cordes","year":"2002","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.adro.2026.102087_bib0026","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.taap.2016.10.021","article-title":"Enterolactone: A novel radiosensitizer for human breast cancer cell lines through impaired DNA repair and increased apoptosis","volume":"313","author":"Bigdeli","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.adro.2026.102087_bib0027","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1080\/09553002.2020.1820609","article-title":"A radiobiological study of carbon ions of different linear energy transfer in resistant human malignant cell lines","volume":"96","author":"Petrovi\u0107","year":"2020","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.adro.2026.102087_bib0028","doi-asserted-by":"crossref","first-page":"9054","DOI":"10.1038\/s41598-020-65680-z","article-title":"Differential miRNAs expression pattern of irradiated breast cancer cell lines is correlated with radiation sensitivity","volume":"10","author":"Masoudi-Khoram","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.adro.2026.102087_bib0029","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13014-021-01829-y","article-title":"Impact of superparamagnetic iron oxide nanoparticles on in vitro and in vivo radiosensitisation of cancer cells","volume":"16","author":"Russell","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0030","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1039\/D4NA00773E","article-title":"Impact of gold nanoparticle size and coating on radiosensitization and generation of reactive oxygen species in cancer therapy","volume":"7","author":"Loscertales","year":"2025","journal-title":"Nanoscale Adv"},{"key":"10.1016\/j.adro.2026.102087_bib0031","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3109\/0284186X.2010.504226","article-title":"Relative biological effectiveness of photon energies used in brachytherapy and intraoperative radiotherapy techniques for two breast cancer cell lines","volume":"49","author":"Marthinsen","year":"2010","journal-title":"Acta Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0032","doi-asserted-by":"crossref","first-page":"N167","DOI":"10.1088\/0031-9155\/55\/7\/N01","article-title":"Counting clonogenic assays from normoxic and anoxic irradiation experiments manually or by using densitometric software","volume":"55","author":"Wouters","year":"2010","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.adro.2026.102087_bib0033","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0360-3016(94)90523-1","article-title":"Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro","volume":"30","author":"Wollman","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0034","doi-asserted-by":"crossref","unstructured":"Sisin NN, Abdullah R, Abdullah AN, et al. A new insight on the effects of Schiff base-iron complex in breast cancer cells for clinical radiotherapy. 2023.","DOI":"10.2139\/ssrn.4652989"},{"key":"10.1016\/j.adro.2026.102087_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105487","article-title":"Trastuzumab and folic acid functionalized gold nanoclusters as a dual-targeted radiosensitizer for megavoltage radiation therapy of human breast cancer","volume":"153","author":"Samani","year":"2020","journal-title":"Eur J Pharma Sci"},{"key":"10.1016\/j.adro.2026.102087_bib0036","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/jpm10040177","article-title":"Local disease-free survival rate (LSR) application to personalize radiation therapy treatments in breast cancer models","volume":"10","author":"Savoca","year":"2020","journal-title":"J Pers Med"},{"key":"10.1016\/j.adro.2026.102087_bib0037","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/radiation6010002","article-title":"In vitro perspective on hypofractionated radiotherapy in breast cancer","volume":"6","author":"du Plessis","year":"2026","journal-title":"Radiation"},{"key":"10.1016\/j.adro.2026.102087_bib0038","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF02966706","article-title":"Biological effects of heavy ion beam on human breast cancers","volume":"5","author":"Matsuzaki","year":"1998","journal-title":"Breast Cancer"},{"key":"10.1016\/j.adro.2026.102087_bib0039","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01990029","article-title":"Proliferative inhibition of human breast carcinoma cells by high concentration estradiol does not alter radiosensitivity","volume":"18","author":"Wazer","year":"1991","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.adro.2026.102087_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/ppsc.201900411","article-title":"Radiobiological implications of nanoparticles following radiation treatment","volume":"37","author":"Ahmad","year":"2020","journal-title":"Part Part Syst Charact"},{"key":"10.1016\/j.adro.2026.102087_bib0041","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ab2154","article-title":"Multifunction bismuth gadolinium oxide nanoparticles as radiosensitizer in radiation therapy and imaging","volume":"64","author":"Rajaee","year":"2019","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.adro.2026.102087_bib0042","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/s10637-021-01106-5","article-title":"Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancer","volume":"39","author":"Abdullah","year":"2021","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.adro.2026.102087_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206713","article-title":"Collective radioresistance of T47D breast carcinoma cells is mediated by a Syncytin-1 homologous protein","volume":"14","author":"Chignola","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.adro.2026.102087_bib0044","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ijrobp.2006.09.038","article-title":"Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells","volume":"67","author":"Gomez-Millan","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0045","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/cells12030360","article-title":"Comparison of radiation response between 2D and 3D cell culture models of different human cancer cell lines","volume":"12","author":"Raitanen","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.adro.2026.102087_bib0046","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00280-002-0557-9","article-title":"Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies","volume":"51","author":"Pauwels","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.adro.2026.102087_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/5485632","article-title":"Radiosensitivity enhancement using triptorelin conjugated bismuth sulfide nanoparticles (Bi2S3@BSA) in radiotherapy for breast cancer cells","volume":"2023","author":"Choghazardi","year":"2023","journal-title":"J Nanomater"},{"key":"10.1016\/j.adro.2026.102087_bib0048","article-title":"Combination therapy with the histone deacetylase inhibitor LBH589 and radiation is an effective regimen for prostate cancer cells","volume":"8","author":"Xiao","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.adro.2026.102087_bib0049","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.ejca.2008.04.013","article-title":"In vitro radiosensitisation by trabectedin in human cancer cell lines","volume":"44","author":"Romero","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2026.102087_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10585-011-9423-7","article-title":"CD44 is a biomarker associated with human prostate cancer radiation sensitivity","volume":"29","author":"Xiao","year":"2012","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.adro.2026.102087_bib0051","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/jrr\/rrae077","article-title":"Elevated \u03b1\/\u03b2 ratio after hypofractionated radiotherapy correlated with DNA damage repairment in an experimental model of prostate cancer","volume":"65","author":"Cui","year":"2024","journal-title":"J Radiat Res"},{"key":"10.1016\/j.adro.2026.102087_bib0052","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12951-021-01019-8","article-title":"Formulating RALA\/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment","volume":"19","author":"Bennie","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.adro.2026.102087_bib0053","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1158\/0008-5472.CAN-03-2749","article-title":"Hyperthermia-induced proteasome inhibition and loss of androgen receptor expression in human prostate cancer cells","volume":"65","author":"Pajonk","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.adro.2026.102087_bib0054","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1088\/0031-9155\/55\/6\/005","article-title":"A study of the biological effects of modulated 6 MV radiation fields","volume":"55","author":"Butterworth","year":"2010","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.adro.2026.102087_bib0055","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/radiation4040029","article-title":"Exploring hypofractionated radiotherapy efficacy in prostate cancer: In vitro insights","volume":"4","author":"du Plessis","year":"2024","journal-title":"Radiation"},{"key":"10.1016\/j.adro.2026.102087_bib0056","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-60585-7","article-title":"First in vitro measurement of VHEE relative biological effectiveness (RBE) in lung and prostate cancer cells using the ARES linac at DESY","volume":"14","author":"Wanstall","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.adro.2026.102087_bib0057","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1631\/jzus.B2000793","article-title":"Pulsed low-dose rate radiotherapy has an improved therapeutic effect on abdominal and pelvic malignancies","volume":"22","author":"Wen","year":"2021","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.adro.2026.102087_bib0058","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/pros.21074","article-title":"Antagonistic interaction between bicalutamide\u2122 (Casodex\u00ae) and radiation in androgen-positive prostate cancer LNCaP cells","volume":"70","author":"Qu\u00e9ro","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.adro.2026.102087_bib0059","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0360-3016(93)90350-5","article-title":"Radiobiological studies of PC-3 and DU-145 human prostate cancer cells: X-ray sensitivity in vitro and hypoxic fractions of xenografted tumors in vivo","volume":"25","author":"Leith","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0060","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ad7d5a","article-title":"Relative biological effectiveness of clinically relevant photon energies for the survival of human colorectal, cervical, and prostate cancer cell lines","volume":"69","author":"Li","year":"2024","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.adro.2026.102087_bib0061","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejmp.2020.08.012","article-title":"RBE variation in prostate carcinoma cells in active scanning proton beams: In-vitro measurements in comparison with phenomenological models","volume":"77","author":"Khachonkham","year":"2020","journal-title":"Phys Med"},{"key":"10.1016\/j.adro.2026.102087_bib0062","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2307\/3579456","article-title":"Radiation inactivation of human prostate cancer cells: The role of apoptosis","volume":"146","author":"Algan","year":"1996","journal-title":"Radiat Res"},{"key":"10.1016\/j.adro.2026.102087_bib0063","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00000421-200110000-00019","article-title":"Chromatin compaction and tumor cell radiosensitivity at 2 gray","volume":"24","author":"Chapman","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0064","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0022-5347(01)63990-9","article-title":"Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure","volume":"159","author":"Deweese","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.adro.2026.102087_bib0065","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1002\/mp.14212","article-title":"Investigating the impact of alpha\/beta and LETd on relative biological effectiveness in scanned proton beams: An in vitro study based on human cell lines","volume":"47","author":"Mara","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0066","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1088\/0031-9155\/58\/10\/3075","article-title":"A Monte Carlo-based model of gold nanoparticle radiosensitization accounting for increased radiobiological effectiveness","volume":"58","author":"Lechtman","year":"2013","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.adro.2026.102087_bib0067","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.phro.2020.11.003","article-title":"Imaging prior to radiotherapy impacts in-vitro survival","volume":"16","author":"Kench","year":"2020","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0068","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0167-8140(95)01591-4","article-title":"Irregular variations in radiation sensitivity when the linear energy transfer is increased","volume":"36","author":"Stenerl\u00f6w","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0069","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1743-7563.2008.00149.x","article-title":"An investigation of fludarabine as a potential radiation sensitizer of human prostate cancer cells in vitro","volume":"4","author":"Barnetson","year":"2008","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0070","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.877302","article-title":"Differential responses to 223Ra and alpha-particles exposure in prostate cancer driven by mitotic catastrophe","volume":"12","author":"Guerra Liberal","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0071","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ijrobp.2007.10.050","article-title":"Radiobiologic parameters and local effect model predictions for head-and-neck squamous cell carcinomas exposed to high linear energy transfer ions","volume":"71","author":"Beuve","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0072","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/jpm10030071","article-title":"Relative biological effectiveness of carbon ions for head-and-neck squamous cell carcinomas according to human Papillomavirus status","volume":"10","author":"Osu","year":"2020","journal-title":"J Pers Med"},{"key":"10.1016\/j.adro.2026.102087_bib0073","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3390\/cells9081788","article-title":"Intrinsic radiosensitivity is not the determining factor in treatment response differences between HPV negative and HPV positive head and neck cancers","volume":"9","author":"Reid","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.adro.2026.102087_bib0074","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.ijrobp.2010.09.003","article-title":"Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay","volume":"81","author":"Calugaru","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152213","article-title":"Exosomes derived from squamous head and neck cancer promote cell survival after ionizing radiation","volume":"11","author":"Mutschelknaus","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.adro.2026.102087_bib0076","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00066-014-0600-x","article-title":"The effect of cilengitide in combination with irradiation and chemotherapy in head and neck squamous cell carcinoma cell lines","volume":"190","author":"Heiduschka","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.adro.2026.102087_bib0077","doi-asserted-by":"crossref","DOI":"10.1177\/1559325819891008","article-title":"The cell cycle G2\/M block is an indicator of cellular radiosensitivity","volume":"17","author":"Liu","year":"2019","journal-title":"Dose Response"},{"key":"10.1016\/j.adro.2026.102087_bib0078","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/jrr\/rrs007","article-title":"Biophysical characterization of a relativistic proton beam for image-guided radiosurgery","volume":"53","author":"Yu","year":"2012","journal-title":"J Radiat Res"},{"key":"10.1016\/j.adro.2026.102087_bib0079","first-page":"1733","article-title":"Heterogeneous nuclear ribonucleoprotein K is overexpressed and contributes to radioresistance irrespective of HPV status in head and neck squamous cell carcinoma","volume":"46","author":"K\u00e4hler","year":"2020","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.adro.2026.102087_bib0080","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/s41419-021-04454-5","article-title":"Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma","volume":"12","author":"Schoetz","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.adro.2026.102087_bib0081","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13014-019-1418-6","article-title":"Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines","volume":"14","author":"Todorovic","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0082","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/09553000050028995","article-title":"Inactivation of human normal and tumour cells irradiated with low energy protons","volume":"76","author":"Belli","year":"2000","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.adro.2026.102087_bib0083","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/cancers4020566","article-title":"An estimation of radiobiological parameters for head-and-neck cancer cells and the clinical implications","volume":"4","author":"Qi","year":"2012","journal-title":"Cancers"},{"key":"10.1016\/j.adro.2026.102087_bib0084","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/cells10030610","article-title":"Resistance of hypoxic cells to ionizing radiation is mediated in part via hypoxia-induced quiescence","volume":"10","author":"Menegakis","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.adro.2026.102087_bib0085","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.21873\/anticanres.14235","article-title":"MALAT1 decreases the sensitivity of head and neck squamous cell carcinoma cells to radiation and cisplatin","volume":"40","author":"Kangboonruang","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.adro.2026.102087_bib0086","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/09553000110066095","article-title":"p53-dependent thermal enhancement of cellular sensitivity in human squamous cell carcinomas in relation to LET","volume":"77","author":"Takahashi","year":"2001","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.adro.2026.102087_bib0087","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1269\/jrr.08052","article-title":"Effectiveness of monoenergetic and spread-out Bragg peak carbon-ions for inactivation of various normal and tumour human cell lines","volume":"49","author":"Belli","year":"2008","journal-title":"J Radiat Res"},{"key":"10.1016\/j.adro.2026.102087_bib0088","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clon.2007.02.007","article-title":"Is the alpha\/beta value for prostate tumours low enough to be safely used in clinical trials?","volume":"19","author":"Da\u015fu","year":"2007","journal-title":"Clin Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0089","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ijrobp.2004.06.204","article-title":"New data on the value of alpha\/beta\u2014Evidence mounts that it is low","volume":"60","author":"Chappell","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0090","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ijrobp.2006.06.005","article-title":"Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: Updated results of a phase III randomized trial","volume":"66","author":"Yeoh","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0091","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijrobp.2006.12.036","article-title":"Use of individual fraction size data from 3756 patients to directly determine the alpha\/beta ratio of prostate cancer","volume":"68","author":"Williams","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0092","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijrobp.2009.10.008","article-title":"Confirmation of a low \u03b1\/\u03b2 ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics","volume":"79","author":"Proust-Lima","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0093","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ijrobp.2010.07.1984","article-title":"Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: Final results of phase III randomized trial","volume":"81","author":"Yeoh","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0094","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ijrobp.2010.10.075","article-title":"Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: \u03b1\/\u03b2 = 1.4 (0.9-2.2) Gy","volume":"82","author":"Miralbell","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0095","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.ijrobp.2010.12.040","article-title":"Later outcomes and alpha\/beta estimate from hypofractionated conformal three-dimensional radiotherapy versus standard fractionation for localized prostate cancer","volume":"82","author":"Leborgne","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0096","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijrobp.2012.03.004","article-title":"Meta-analysis of the alpha\/beta ratio for prostate cancer in the presence of an overall time factor: Bad news, good news, or no news?","volume":"85","author":"Vogelius","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0097","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1016\/j.ijrobp.2012.11.033","article-title":"Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer","volume":"85","author":"Pedicini","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0098","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2005.06.009","article-title":"The alpha\/beta ratio for prostate cancer: What is it, really?","volume":"76","author":"Bentzen","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0099","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.radonc.2010.06.006","article-title":"Which \u03b1\/\u03b2 ratio and half-time of repair are useful for predicting outcomes in prostate cancer?","volume":"97","author":"Nickers","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0100","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.radonc.2011.07.017","article-title":"Long-term biochemical control of prostate cancer after standard or hyper-fractionation: Evidence for different outcomes between low-intermediate and high risk patients","volume":"101","author":"Valdagni","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0101","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0360-3016(00)00442-9","article-title":"Is the prostate \u03b1\/\u03b2 ratio of 1.5 from Brenner & Hall a modeling artifact?","volume":"47","author":"King","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0102","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0360-3016(00)00443-0","article-title":"In response to Drs. King and Mayo: Low \u03b1\/\u03b2 values for prostate appear to be independent of modeling details","volume":"47","author":"Brenner","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0103","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0360-3016(01)01607-8","article-title":"Is \u03b1\/\u03b2 for prostate tumors really low?","volume":"50","author":"Fowler","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0104","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0360-3016(01)02664-5","article-title":"Direct evidence that prostate tumors show high sensitivity to fractionation (low \u03b1\/\u03b2 ratio), similar to late-responding normal tissue","volume":"52","author":"Brenner","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0105","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0360-3016(02)03828-2","article-title":"How low is the \u03b1\/\u03b2 ratio for prostate cancer?","volume":"55","author":"Wang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0106","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0360-3016(98)00438-6","article-title":"Fractionation and protraction for radiotherapy of prostate carcinoma","volume":"43","author":"Brenner","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0107","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150957","article-title":"Alpha\/beta (\u03b1\/\u03b2) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost","volume":"89","author":"Boonstra","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.adro.2026.102087_bib0108","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3109\/0284186X.2012.719635","article-title":"Prostate alpha\/beta revisited\u2014An analysis of clinical results from 14 168 patients","volume":"51","author":"Dasu","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0109","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1470-2045(06)70699-4","article-title":"Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial","volume":"7","author":"Owen","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0110","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0111","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","article-title":"Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial","volume":"75","author":"Yarnold","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0112","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"9","author":"Abram","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0113","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.radonc.2011.01.010","article-title":"Is \u03b1\/\u03b2 for breast cancer really low?","volume":"100","author":"Qi","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0114","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0360-3016(89)90503-8","article-title":"Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: Tumor dose-response and repopulation","volume":"16","author":"Maciejewski","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0167-8140(92)90323-M","article-title":"The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer","volume":"23","author":"Barton","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0116","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1259\/0007-1285-66-783-245","article-title":"Sensitivity of human squamous cell carcinoma of the larynx to fractionated radiotherapy","volume":"66","author":"Rezvani","year":"1993","journal-title":"Br J Radiol"},{"key":"10.1016\/j.adro.2026.102087_bib0117","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1259\/0007-1285-67-800-790","article-title":"The influence of radiotherapy treatment time on the control of laryngeal cancer: A direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor","volume":"67","author":"Roberts","year":"1994","journal-title":"Br J Radiol"},{"key":"10.1016\/j.adro.2026.102087_bib0118","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0360-3016(95)00133-J","article-title":"Further analysis of radiobiological parameters from the First and Second British Institute of Radiology randomized studies of larynx\/pharynx radiotherapy","volume":"33","author":"Chappelg","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0119","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0959-8049(05)80139-X","article-title":"The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx","volume":"29","author":"Robertson","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2026.102087_bib0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0360-3016(95)00528-7","article-title":"Heterogeneity in the fractionation sensitivities of human tumor cell lines: Studies in a three-dimensional model system","volume":"32","author":"Stuschke","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0121","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0167-8140(97)00222-3","article-title":"Repopulation during radical radiotherapy for T1 glottic cancer","volume":"47","author":"Saarilahti","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0122","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0360-3016(97)00716-5","article-title":"Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers","volume":"40","author":"Robertson","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0123","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-8140(99)00042-0","article-title":"Fractionation sensitivities and dose-control relations of head and neck carcinomas: Analysis of the randomized hyperfractionation trials","volume":"51","author":"Stuschke","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0124","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13014-022-02010-9","article-title":"Variability of \u03b1\/\u03b2 ratios for prostate cancer with the fractionation schedule: Caution against using the linear-quadratic model for hypofractionated radiotherapy","volume":"17","author":"Cui","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0125","article-title":"Demystifying the radiobiology of hypofractionation: Simple equations to determine tumour alpha beta ratio","volume":"3","author":"Joseph","year":"2025","journal-title":"R Coll Radiol Open"},{"key":"10.1016\/j.adro.2026.102087_bib0126","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0360-3016(91)90314-T","article-title":"The dose\u2011rate effect revisited: radiobiological considerations of importance in radiotherapy","volume":"21","author":"Hall","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0127","doi-asserted-by":"crossref","first-page":"357","DOI":"10.21037\/tau.2017.12.08","article-title":"High dose\u2011rate brachytherapy in the treatment of prostate cancer","volume":"7","author":"Mendez","year":"2018","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.adro.2026.102087_bib0128","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50908-4","article-title":"Multiparametric radiobiological assays show that variation of X\u2011ray energy strongly impacts relative biological effectiveness: Comparison between 220 kV and 4 MV","volume":"9","author":"Paget","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.adro.2026.102087_bib0129","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0360-3016(84)90301-8","article-title":"Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis and a survey of existing data","volume":"10","author":"Moulder","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102087_bib0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semcancer.2023.11.006","article-title":"Tumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities","volume":"98","author":"Beckers","year":"2024","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.adro.2026.102087_bib0131","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fonc.2020.00164","article-title":"The role of cancer stem cells in radiation resistance","volume":"10","author":"Arnold","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.adro.2026.102087_bib0132","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20160441","article-title":"Tumour and normal tissue radiobiology in mouse models: How close are mice to mini-humans?","volume":"90","author":"Koontz","year":"2017","journal-title":"Br J Radiol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426000941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426000941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:35:44Z","timestamp":1786707344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109426000941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":132,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2452109426000941"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2026.102087","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of In Vitro and Clinical Alpha\/Beta Estimates With Potential Impact of Tumor Heterogeneity","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2026.102087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"102087"}}